[1]
“Post-Approval Change Management for Modified Release Solid Oral Dosage Forms: A Comparative Regulatory Review of the United States, the Republic of Korea and the GCC Variation Guidelines”, Int. J. Pharm. Sci. Drug Res., vol. 18, no. 5, pp. 272–279, Sep. 2026, doi: 10.25004/IJPSDR.2026.180504.